T1	Participants 104 140	patients with treated HIV infection:
T2	Participants 564 702	Thirty-one subjects with an ART-suppressed plasma HIV RNA level of <40 copies/mL and a CD4(+) T-cell count of ≥350 cells/mm(3) for ≥1 year
